Accounting standard newly cited
Filing comparison
Cocrystal Pharma, Inc. cited accounting standard ASU 2023-09 for the first time in this filing series
Upon adoption of ASU 2023-09, Improvements to Income Tax Disclosures, the reconciliation of taxes at the federal statutory rate to our provision for (benefit from) income taxes for the year ended December 31,2025 was as follows (in thousands, except for percentages): Schedule of Reconciliation of Federal Statutory Income Tax Rate Year Ended December 31, 2025 Tax Computed at federal statutory rate…
Evidence
- Adopted
- 2023-09
- Contexts
- Upon adoption of ASU 2023-09, Improvements to Income Tax Disclosures, the reconciliation of taxes at the federal statutory rate to our provision for (benefit from) income taxes for the year ended December 31,2025 was as follows (in thousands, except for percentages): Schedule of Reconciliation of Federal Statutory Income Tax Rate Year Ended December 31, 2025 Tax Computed at federal statutory rate…
- New standards
- 2023-09
- Prior filed
- 2025-03-31
- Prior form
- 10-K
- Restates existing policy
- No
- Source
- accounting standards update (ASU) reference comparison
- Why
- An accounting standard (ASU) appears in this filing that did not appear in the previous comparable one, in a sentence describing it as adopted. That is a change in what the company discloses, which is not always a change of policy in the current period: the filing may state an adoption date years earlier.